New technology will be in place from January 31 to monitor advertisements on social media relating to the promotion of prescription-only medicines (POMs) such as botulinum toxin.
The Advertising Standards Authority (ASA) has upheld its decision for skincare supplement brand Dermacoll to revoke marketing claims in regards to a collagen drink it was promoting on its website.
The Advertising Standards Authority (ASA) has upheld a decision to ban a clinic’s marketing materials advertising injectable vitamin D and vitamin B12.
Medical aesthetic company Evolus Inc has announced that the European Commission (EC) has approved the marketing of Nuceiva prabotulinumtoxinA (branded Jeuveau in the US and known in other markets as Nabota).
A new European Standard on non-surgical aesthetics has been published by the British Standards Institution (BSI).
The Advertising Standards Authority (ASA) has banned an Instagram post by Beauty Boutique Aesthetics after a complaint regarding misleading advertising and the advertisement of a prescription-only medicine.
The Committees of Advertising Practice (CAP) and Medicines and Healthcare products Regulatory Agency (MHRA) have issued an Enforcement Notice to the beauty and cosmetic services industry urging businesses to review adverts and make immediate changes.
Healthcare Improvement Scotland (HIS) has confirmed in a Stakeholder meeting earlier this week that aesthetic nurses who own HIS-registered clinics can now legally stock prescription only medications (POMs) such as botulinum toxin and hyaluronidase on premises.
The Committees of Advertising Practice (CAP) has issued an Enforcement Notice following recent reports of education providers not adhering to its advertising rules for promoting training for injectable procedures.
The Joint Council for Cosmetic Practitioners (JCCP) has raised concerns over vague and misleading advertising language used by aesthetic training companies to the Advertising Standards Authority (ASA).